This finding will contribute to the understanding of cartilage diseases caused by genomic mutation and genome - based drug discovery for disease therapies. (sciencedaily.com)
Based on positive results produced from a number of scientific clinical trials, coronary artery disease therapy using adult stem cells is a promising new method of treatment for coronary artery disease patients. (okyanos.com)
After Heron Therapeutics Inc (NASDAQ: HRTX), Bristol - Myers Squibb Co (NYSE: BMY) and Dynavax Technologies Corporation (NASDAQ: DVAX) found favor with the FDA, it's Ultragenyx Pharmaceutical Inc (NASDAQ: RARE)'s turn, as the rare disease therapy company seeks FDA approval for its... (benzinga.com)